| Product Code: ETC12282885 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
China import shipments of furosemide in 2024 saw significant growth, with top exporting countries including India, Japan, China, Mexico, and Italy. The market concentration, as measured by the HHI, remained high in 2024 after being very high in the previous year. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 1.49%, while the growth rate from 2023 to 2024 spiked at an impressive 85.8%. These trends suggest a continued strong demand for furosemide in China, driven by imports from a diverse group of key suppliers.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Furosemide Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Furosemide Market Revenues & Volume, 2021 & 2031F |
3.3 China Furosemide Market - Industry Life Cycle |
3.4 China Furosemide Market - Porter's Five Forces |
3.5 China Furosemide Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Furosemide Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Furosemide Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Furosemide Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Furosemide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in China |
4.2.2 Growing geriatric population in China requiring furosemide for various health conditions |
4.2.3 Rise in healthcare infrastructure and access to healthcare services in China |
4.3 Market Restraints |
4.3.1 Stringent government regulations and policies related to pharmaceuticals |
4.3.2 Presence of alternative treatments and medications impacting furosemide market growth |
5 China Furosemide Market Trends |
6 China Furosemide Market, By Types |
6.1 China Furosemide Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Furosemide Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 China Furosemide Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 China Furosemide Market Revenues & Volume, By Injectable Formulations, 2021 - 2031F |
6.1.5 China Furosemide Market Revenues & Volume, By Oral Liquid, 2021 - 2031F |
6.2 China Furosemide Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Furosemide Market Revenues & Volume, By Heart Failure, 2021 - 2031F |
6.2.3 China Furosemide Market Revenues & Volume, By Hypertension, 2021 - 2031F |
6.2.4 China Furosemide Market Revenues & Volume, By Kidney Disease, 2021 - 2031F |
6.2.5 China Furosemide Market Revenues & Volume, By Liver Disease, 2021 - 2031F |
6.3 China Furosemide Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Furosemide Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Furosemide Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.4 China Furosemide Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4 China Furosemide Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Furosemide Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.3 China Furosemide Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 China Furosemide Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
7 China Furosemide Market Import-Export Trade Statistics |
7.1 China Furosemide Market Export to Major Countries |
7.2 China Furosemide Market Imports from Major Countries |
8 China Furosemide Market Key Performance Indicators |
8.1 Number of prescriptions for furosemide by healthcare providers in China |
8.2 Adoption rate of furosemide in different healthcare facilities |
8.3 Patient adherence and compliance rates to furosemide treatment plans |
8.4 Number of clinical trials and research studies focused on furosemide efficacy and safety in China |
8.5 Availability and accessibility of furosemide in pharmacies and hospitals across different regions in China |
9 China Furosemide Market - Opportunity Assessment |
9.1 China Furosemide Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Furosemide Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Furosemide Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Furosemide Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Furosemide Market - Competitive Landscape |
10.1 China Furosemide Market Revenue Share, By Companies, 2024 |
10.2 China Furosemide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |